Takeaways
- Menopause and TBI share overlapping symptoms, especially in neurocognitive, mood, and somatosensory domains.
- Standard concussion assessment tools lack hormone-specific questions, which may hinder accurate diagnosis and recovery monitoring in women.
- Integrating neuroendocrine and vasomotor symptoms into TBI evaluation could improve personalized treatment and outcomes for menopausal women.
Despite increasing recognition of sex differences in traumatic brain injury (TBI) outcomes, the interaction between menopause and brain injury remains largely unexplored. New research presented at The Menopause Society’s 2025 Annual Meeting in Orlando emphasizes the need to consider hormonal transitions when diagnosing and treating TBIs in women.1,2
The study, Toward Hormone-Informed Brain Injury Care: Unifying Assessment for Menopause and TBI in Women, was led by Katherine E. Buzzanca-Fried, PhD, of the University of Florida College of Public Health and Health Professions. The research team sought to examine how the menopause transition, a period characterized by significant neuroendocrine changes, may influence post-concussive symptom expression, recovery, and chronicity among women.
“Emerging evidence suggests that hormonal changes can significantly influence both physiological and cognitive functioning after traumatic brain injury, even in milder injuries such as concussion,” said Buzzanca-Fried. “It’s essential that health care providers consider hormonal factors, particularly during the menopause transition, so we can better understand recovery trajectories, design targeted interventions, and communicate more inclusively with patients.”
Assessment tools lack hormone consideration
Currently, standard TBI assessment tools, such as the Sports Concussion Assessment Tool (SCAT-5), General Symptom Checklist (GSC-30), and Rivermead Post-Concussion Questionnaire (RPQ), do not account for hormonal status. According to the investigators, this omission may delay recovery, increase symptom burden, or obscure accurate symptom attribution in women.
To address this gap, the research team conducted a qualitative review and comparative analysis of validated assessment instruments used in both TBI and menopause. These included the Menopause Rating Scale (MRS) and the Menopause-specific Quality of Life (MenQOL) questionnaire. The researchers extracted 108 symptom items across tools and mapped them into symptom domains to identify overlap and divergence between menopause- and TBI-related symptoms.